Rosiglitazone/Metformin: A Viewpoint by William L. Isley

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.11, 2005-01, pp. : 1593-1594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rosiglitazone/Metformin

By Wellington Keri

Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. : 1581-1592

Adis International

Access to resources Recommend Favorite

Rosiglitazone/metformin: Exophthalmos: case report

Reactions Weekly, Vol. 1, Iss. 1153, 2007-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Metformin Extended Release: A Viewpoint by Jason L. Iltz

By Iltz Jason L.

American Journal of Drug Delivery, Vol. 4, Iss. 3, 2006-01 ,pp. : 187-188

Adis International

Access to resources Recommend Favorite

The French launch of the type 2 diabetes mellitus combination treatment rosiglitazone/metformin [Avandamet] has been announced

Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Propionyl- L -Carnitine: A Viewpoint by William R. Hiatt

By Hiatt W.R.

Drugs & Aging, Vol. 12, Iss. 3, 1998-03 ,pp. : 249-249

Adis International

Access to resources Recommend Favorite